Related Experiment Video
Updated: Feb 27, 2026

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
2.0K
The Panomics Approach in Neurodegenerative Disorders
Balazs Szatmari1, Peter Balicza2, Gyorgy Nemeth1
1Medical Division, Gedeon Richter Plc., Budapest, Hungary.
Current Medicinal Chemistry
|July 8, 2017
Summary
Advances in molecular genetics and omics technologies are transforming the understanding of complex and neurodegenerative disorders. A multidisciplinary approach integrating panomics is crucial for future therapeutic research.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Molecular genetic technologies and omics have advanced disorder diagnostics and understanding of complex diseases.
- Genome-wide association studies often fail to fully explain the genetic basis of complex disorders, despite strong heritability.
- Traditional neurodegenerative disorder classification relied on clinical and morphological signs.
Purpose of the Study:
- Discuss the evolving concept of neurodegenerative disorders.
- Highlight the role of identifying signature lesions and common pathological pathways.
- Emphasize the contribution of new neuroimaging methods and genetics.
Main Methods:
- Review of molecular genetic technologies and omics data.
- Analysis of neuroimaging advancements for in vivo assessment.
- Examination of genetic mutation associations with neurodegenerative disorders.
Main Results:
- Neuroimaging visualizes in vivo amyloid deposits and neuroinflammation, enhancing understanding.
- Genetics offers precise insights but true associations are limited for many disorders.
- Most neurodegenerative disorders appear multifactorial, not linked to single genetic causes.
Conclusions:
- A shift towards a multidisciplinary approach is needed for neurodegenerative diseases.
- Integrating panomics findings will improve understanding and guide therapeutic research.
- Modern classification should move beyond symptomatology to encompass evolving scientific data.
Related Concept Videos
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K

